PowerUp Acquisition terminates merger with Visiox Pharmaceuticals on July 19

Aspire Biopharma Holdings, Inc.

Terminated Merger Agreement with Visiox Pharmaceuticals due to failure to satisfy closing conditions by June 30, 2024.
Company intends to continue evaluating other business combination targets but provides no assurance.
Termination effective July 19, 2024; no transaction resulted.
No financial terms of the abandoned merger were disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.